Romiplostim drug presence in pregnancy and lactation

2.

Chua

SJ

,

Morton

MR

,

Svigos

J

,

Ross

DM

,

Kane

S

.

Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: two case reports with maternal and fetal outcomes and literature review

.

Obstet Med

.

2018

;

13

:

45

-

50

.

3.

Chon

AH

,

Chan

R

,

Lee

RH

,

Kwong

K

,

Wertheimer

FB

,

Weitz

IC

.

Multidrug therapy for refractory immune thrombocytopenia in pregnancy

.

Obstet Gynecol

.

2020

;

135

(

3

):

723

-

727

.

4.

Samuelson Bannow

B

,

Kreuziger

LB

.

Use of romiplostim for refractory primary immune thrombocytopenia during pregnancy

.

Clin Obstet Gynecol Reprod Med

.

2017

;

3

(

1

):

1

-

3

.

5.

Maria

RNR

,

Laura

RL

,

Angeles

PB

,

Laura

LB

.

Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: literature review and case description

.

Platelets

.

2019

;

31

(

3

):

1

-

4

.

6.

Decroocq

J

,

Marcellin

L

,

Le Ray

C

,

Willems

L

.

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy

.

Obstet Gynecol

.

2014

;

124

(

2 Pt 2 suppl 1

):

481

-

483

.

7.

Patil

AS

,

Dotters-Katz

SK

,

Metjian

AD

,

James

AH

,

Swamy

GK

.

Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy

.

Obstet Gynecol

.

2013

;

122

(

2 Pt 2

):

483

-

485

.

8.

Agarwal

N

,

Mangla

A

.

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review

.

Ther Adv Hematol

.

2021

;

12

:

20406207211001139

.

9.

Patras

A

,

Figueroa

R

,

Singh

AP

,

Madan

I

.

Romiplostim for management of refractory immune thrombocytopenia in the immediate postpartum period

.

BMJ Case Rep

.

2020

;

13

(

5

):

e234335

.

10.

Kuter

DJ

,

Bussel

JB

,

Lyons

RM

, et al.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

.

Lancet

.

2008

;

371

(

9610

):

395

-

403

.

11.

Kuter

DJ

.

Biology and chemistry of thrombopoietic agents

.

Semin Hematol

.

2010

;

47

(

3

):

243

-

248

.

https://www.freepatentsonline.com/y2003/0176352.html.

12.

Min

H

,

Sitney

KC

,

Hartley

C

. Peptides and related compounds having thrombopoietic activity.

2003

13.

Syme

MR

,

Paxton

JW

,

Keelan

J a

.

Drug transfer and metabolism by the human placenta

.

Clin Pharmacokinet

.

2004

;

43

(

8

):

487

-

514

.

14.

Schneider

H

,

Miller

RK

.

Receptor-mediated uptake and transport of macromolecules in the human placenta

.

Int J Dev Biol

.

2010

;

54

(

2-3

):

367

-

375

.

15.

Nakai

K

,

Misugi

T

,

Kitada

K

, et al.

Effect of thrombopoietin receptor agonist on pregnant mice

.

Pharmaceutics

.

2022

;

14

(

3

):

514

.

16.

Sparger

KA

,

Ramsey

H

,

Lorenz

V

, et al.

Developmental differences between newborn and adult mice in response to romiplostim

.

Platelets

.

2018

;

29

(

4

):

365

-

372

.

17.

Mahat

U

,

Talati

R

,

Kodish

E

.

Comment on: use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia

.

Pediatr Blood Cancer

.

2019

;

66

(

6

):

e27706

.

18.

Wiedmeier

SE

,

Henry

E

,

Sola-Visner

MC

,

Christensen

RD

.

Platelet reference ranges for neonates, defined using data from over 47000 patients in a multihospital healthcare system

.

J Perinatol

.

2009

;

29

(

2

):

130

-

136

.

19.

Ishiguro

A

,

Nakahata

T

,

Matsubara

K

, et al.

Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels

.

Br J Haematol

.

1999

;

106

(

4

):

884

-

888

.

20.

Kao

Y-R

,

Chen

J

,

Narayanagari

S-R

, et al.

Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag

.

Sci Transl Med

.

2018

;

10

(

458

):

eaas9563

.

21.

Sun

H

,

Tsai

Y

,

Nowak

I

,

Liesveld

J

,

Chen

Y

.

Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis

.

Stem Cell Res

.

2012

;

9

(

2

):

77

-

86

.

22.

Lee

JW

,

Lee

SE

,

Jung

CW

, et al.

Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial

.

Lancet Haematol

.

2019

;

6

(

11

):

e562

-

e572

.

23.

Jang

JH

,

Tomiyama

Y

,

Miyazaki

K

, et al.

Efficacy and safety of romiplostim in refractory aplastic anaemia: a phase II/III, multicentre, open-label study

.

Br J Haematol

.

2021

;

192

(

1

):

190

-

199

.